Showing results (21-30 of 324) with videos related to
Sort By:
Pageof 33
Current Drug Safety|June 19, 2009
Safety of the thrombopoiesis-stimulating agents for the treatment of immune thrombocytopeniaAdam Cuker, Elaine Y Chiang, Douglas B CinesPresse Medicale (Paris, France : 1983)|March 18, 2014
Pathogenesis of immune thrombocytopeniaDouglas B Cines, Adam Cuker, John W SempleJournal of Pediatric Hematology/Oncology|December 12, 2003
Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpuraDouglas B Cines, Steven E McKenzie, Don L SiegelThrombosis and Haemostasis|August 5, 2016
Role of monocytes and endothelial cells in heparin-induced thrombocytopeniaDaria Madeeva, Douglas B Cines, Mortimer Poncz, et al.Seminars in Hematology|May 14, 2013
Innate and adaptive immunity in immune thrombocytopeniaAlan H Lazarus, John W Semple, Douglas B CinesSeminars in Thrombosis and Hemostasis|March 21, 2015
Can immune thrombocytopenia be cured with medical therapy?Adam Cuker, Eline T Luning Prak, Douglas B CinesBlood Reviews|November 24, 2019
Thrombocytopenia in pregnancy: Diagnosis and approach to managementAllyson M Pishko, Lisa D Levine, Douglas B CinesThe Journal of Biological Chemistry|March 19, 2003
Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cellsSreerama Shetty, Khalil Bdeir, Douglas B Cines, et al.Brain Research. Developmental Brain Research|August 16, 2005
Plasminogen activators contribute to age-dependent impairment of NMDA cerebrovasodilation after brain injuryWilliam M Armstead, Douglas B Cines, Abd Al-Roof HigazieBlood|June 29, 2012
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatmentWaleed Ghanima, Bertrand Godeau, Douglas B Cines, et al.Pageof 33